相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluation of HER2/neu Status by Immunohistochemistry Using Computer-Based Image Analysis and Correlation With Gene Amplification by Fluorescence In Situ Hybridization Assay
Venetia R. Sarode et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2015)
Trastuzumab in small tumours and in elderly women
Joan Albanell et al.
CANCER TREATMENT REVIEWS (2014)
HER2 staining intensity in HER2-positive disease: relationship with FISH amplification and clinical outcome in the HERA trial of adjuvant trastuzumab
L. Zabaglo et al.
ANNALS OF ONCOLOGY (2013)
Impact of Her-2-Targeted Therapy on Overall Survival in Patients With Her-2 Positive Metastatic Breast Cancer
Anna S. Berghoff et al.
BREAST JOURNAL (2013)
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Neoadjuvant Chemotherapy and Targeted Therapy in Breast Cancer: Past, Present, and Future
Simon P. Gampenrieder et al.
JOURNAL OF ONCOLOGY (2013)
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
Dennis Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
HER2 ASCO guidelines. The answer to everything?
E. Burandt et al.
PATHOLOGE (2010)
Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival
S. J. Dawson et al.
BRITISH JOURNAL OF CANCER (2009)
HER-2/neu assessment in breast cancer using the original FDA and new ASCO/CAP guideline recommendations: Impact on selecting patients for herceptin therapy
Matteo Brunelli et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Testing for HER2-positive breast cancer: a systematic review and cost-effectiveness analysis
Nandini Dendukuri et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2007)
Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer
H Joensuu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
MJ Piccart-Gebhart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
EH Romond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
分享论文
